NCT07386158 2026-02-04Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCCSun Yat-sen UniversityPhase 2 Recruiting21 enrolled
NCT07047001 2025-07-09Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell CarcinomaSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2 Active not recruiting60 enrolled